Overview
Status
Active
Registry date
2010-01-25
Share capital
1,000,000.00 PLN
Registered address
Taśmowa 7, 02-677 Warszawa, Poland
Electronic delivery address
AE:PL-91051-28278-DUGHD-30
Financials
Revenue history (in m)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 7 days late). All were audited by a statutory auditor.
- 202610/06/2026
- 202529/05/2025
- 202403/06/2024
- 202313/06/2023
- 202223/06/2022
- 202122/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2026.
Results vs industry
Revenue
This companyUSD 178.50mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 2.97mMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 171.98mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 118.73mMedianUSD 608.93kAverageUSD 11.85m
Industry
Trademarks
Accord Healthcare Polska holds 3 active trademarks registered with the Polish Patent Office. The first mark was filed in 2017.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| NAJTAŃSZE LEKI DLA KAŻDEGO | Z.474347 | 5, 35 | Protected | Jul 19, 2027 | |
| BigOne(word) | Z.472705 | 5 | Protected | Jun 8, 2027 | |
| NaBull Accord(word) | Z.470809 | 5 | Protected | Apr 24, 2027 |
| Mark | Protected until | |
|---|---|---|
| NAJTAŃSZE LEKI DLA KAŻDEGO | Jul 19, 2027 | |
| BigOne(word) | Jun 8, 2027 | |
| NaBull Accord(word) | Apr 24, 2027 |
Authorized Representatives
John Paul Bednarek – Management Board Member
Jamie Sparrow – Management Board Member
Jan Piotr Rogoń – Management Board Member
Piotr Karol Olbrycht – Management Board Member
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Accord Healthcare Limited | 20,000 | $270,124.26 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-04-27.
15 1280 0003 0000 0031 8554 3025
19 1030 1508 0000 0008 1888 4009
26 1280 0003 0000 0031 8554 3021
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 19,655PLN 19,655 |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrala Farmaceutyczna CefarmS.A. | $457,052,669.59 | cefarm.com.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Servier Polska Servicessp. z o.o. | $125,526,921.78 | servier.pl | ||
| ITPS.A. | $55,285,362.18 | itpsa.pl | ||
| IMC Impomed CentrumS.A. | $4,447,564.10 | impomed.pl | ||
| Gtm-Mobil M-T T.Walisiewiczsp. k. | $3,438,533.82 | gtmmobil.com.pl | ||
| Reynolds Medicalsp. z o.o. | $3,313,657.78 | reymed.pl | ||
| Petronafsp. z o.o. | $2,499,010.09 | petronaf.com | ||
| CryoprofilS.A. | $1,470,469.25 | cryoprofil.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com |
Change history
| Date | Event | |
|---|---|---|
| 2020-05-21 | Share capital increase (100,050.00 PLN → 1,000,000.00 PLN) | |
| 2019-10-08 | Share capital increase (100,000.00 PLN → 100,050.00 PLN) | |
| 2019-03-28 | PKD change (Removed: 4 codes; Added: 4 codes) | |
| 2017-04-13 | PKD change (Removed: 73.20.Z, 74.90.Z; Added: 21.20.Z, 82.92.Z) | |
| 2015-06-18 | PKD change (Removed: 8 codes; Added: 3 codes) |
FAQ
The main business activity of Accord Healthcare Polska focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on January 25, 2010.
The headquarters is located at: Taśmowa 7, 02-677 Warszawa.
The share capital of the company is PLN 1,000,000 (approx. $270,124).
The latest available financial statement covers the period from April 1, 2025 to March 31, 2026.
In 2026, the company generated total revenue of $178,502,388, representing a decrease of 7.1% compared to 2025.
Yes, the company recorded a net profit of $2,972,427 in 2026, meaning the company decreased its profit by 60.9%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $137,855,375 in 2026, representing 80% of all operating expenses.
Last updated: 2026-10-07